Cell therapy company Talaris Therapeutics raises $100m in Series A round
Talaris Therapeutics (formerly Regenerex) has raised $100 million in a Series A financing round to advance its allogeneic cell therapy
Continue reading
Tag: Scott Requadt
Latest Pharma Industry News
-
Guselkumab meets primary endpoints in phase 3 psoriatic arthritis program
-
ZULRESSO postpartum depression drug set to be launched in US by Sage Therapeutics
-
US neurobehavioral health company BlackThorn raises $76m to advance AI-driven targeted therapeutics
-
Pixuvri EMA approval : Servier NHL drug secures standard marketing authorization in Europe
-
OSSIO launches OSSIOfiber Bone Pin for hammertoe correction in US
-
Boston Scientific to acquire spinal medical devices manufacturer Vertiflex
-
Pfizer opens $200m biologics clinical manufacturing facility in Andover, MA
-
Imricor to install MRI ablation Center in Haga Hospital in The Hague
-
SHINE breaks ground on medical isotope production facility in Janesville, WI
-
Greiner Bio-One launches new MiniCollect K2EDTA Capillary Collection Tube
Business News Today
- Expanded Lamb Weston french fry processing plant in Hermiston begins operations
- Mozambique LNG project FID taken by Anadarko and partners
- India’s Hexaware acquires US digital consultancy firm Mobiquity for $182m
- Reliance, BP to move ahead with new Krishna-Godavari Basin gas project
- Kudankulam Nuclear Power Project : BHEL wins contract to erect third and fourth units
- Central Co-op opens new store in Tacoma, Washington
- Mondelez to invest in Reading Science Centre in UK for product development
- BDT to acquire majority stake in fast food restaurant chain Whataburger
- SC Johnson to acquire personal care products brand Sun Bum
- Jackson Mitchell acquires supermarket chain Little Giant Farmer’s Market
